Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.

By H. Okayama, T. Kohno, Y. Ishii, Yoko Shimada, K. Shiraishi, Reika Iwakawa, K. Furuta, K. Tsuta, T. Shibata, Seiichiro Yamamoto and 11 more. Cancer Research, 2012

814 citations recorded by the source corpus.

Subfields: Molecular Biology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/34823837a3acf1631d01db88f05de0b7009cefad

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Emmanuel Martínez-Ledesma
2. Hugo Gómez-Rueda
3. R. Aguirre-Gamboa
4. Jose Gerardo Tamez-Peña
5. A. Martínez-Torteya
6. Rafael Chacolla-Huaringa
7. Alberto Rodriguez-Barrientos
8. V. Treviño

Citations in the corpus

• EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII). (2015, neutral): “Japan 9 [60, 61, 68, 69, 74, 76, 77, 80, 82] 549/829 66 57-83 326/919 35 26-54”
• SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis (2013, methodology): “We used a special lung meta-base build in our research group, which is composed of more than 1,000 samples obtained from six authors (Bild [19], Raponi [20], Zhu [21], Hou [22], NCI [23], Okayama [24]), equivalent Affymetrix gene expression platform, and containing all biomarker genes.”